SEARCH

SEARCH BY CITATION

References

  • 1
    Supuran C.T., Scozzafava A. (2001) Carbonic anhydrase inhibitors. Curr Med Chem Immunol Endocrinol Metab Agents;1:6197.
  • 2
    Iizawa Y., Okonogi K., Hayashi R., Iwahi T., Yamazaki T., Imada A. (1993) Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice. Antimicrob Agents Chemother;37:100105.
  • 3
    Onkol T., Doruer D.S., Uzun L., Adak S., Ozkan S., Ahin F.M. (2008) Synthesis and antimicrobial activity of new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. J Enz Inhib Med Chem;23:277284.
  • 4
    Matysiak J., Malinski Z. (2007) 2-(2,4-dihydroxyphenyl)-1,3,4 thiadiazole analogues: antifungal activity In Vitro against Candida species. Russ J Bioorg Chem;33:594601.
  • 5
    Abdel-Wahab B.F., Abdel-Aziz H.A., Ahmed E.M. (2009) Synthesis and antimicrobial evaluation of some 1,3-thiazole, 1,3,4-thiadiazole, 1,2,4-triazole, and 1,2,4-triazolo[3,4-b] [1,3,4]-thiadiazine derivatives including a 5-(benzofuran-2-yl)-1-phenylpyrazole moiety. Monatsh Chem;140:601605.
  • 6
    Kadi A.A., Al-Abdullah E.S., Shehata I.A., Habib E.A., Ibrahim T.M., El-Emam A.A. (2010) Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives. Eur J Med Chem;45:50065011.
  • 7
    Kadi A.A., El-Brollosy N.R., Al-Deeb O.A., Habib E.E., Ibrahim T.M., El-Emam A.A. (2007) Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles. Eur J Med Chem;42:235242.
  • 8
    Verma S., Srivastava S.K., Samadhiya P. (2011) Synthesis and antimicrobial activity of thiazolidine derivatives of thiazole. Int J Pharm Res Dev;11:7381.
  • 9
    Bhat A.R., Tazeem, Azam A., Choi I., Athar F. (2011) 3-(1,3,4-Thiadiazole-2-yl)quinoline derivatives: synthesis, characterization and anti-microbial activity. Eur J Med Chem;46:31583166.
  • 10
    He Y., Cao L., Zhang J., Wang D., Aisa H.A. (2011) Synthesis and bioactivity of 5-(1-aryl-1H-tetrazol-5-ylsulfanylmethyl)-N-xylopyranosyl-1,3,4-oxa(thia)diazol-2-amines. Carbohydrate Res;346:551559.
  • 11
    Padmavathi V., Reddy G.D., Reddy S.N., Mahesh K. (2011) Synthesis and biological activity of 2-(bis((1,3,4-oxadiazolyl/1,3,4-thiadiazolyl) methylthio) methylene)malononitriles. Eur J Med Chem;46:13671373.
  • 12
    Khalaj A., Nakhjiri N., Negahbani A.S., Samadizadeh M., Firoozpour L., Rajabalian S., Samadi N., Faramarzi M.A., Adibpour N., Shafiee A., Foroumadi A. (2011) Discovery of a novel nitroimidazolyleoxazolidinone hybrid with potent anti Gram-positive activity: synthesis and antibacterial evaluation. Eur J Med Chem;46:6570.
  • 13
    Tomi I.H.R., Al-Daraji A.H.R., Al-Qaysi R.R.T., Hasson M.M., Al-Dulaimy K.H.D. (2010) Synthesis, characterization and biological activities of some azo derivatives of aminothiadiazole derived from nicotinic and isonicotinic acids. Arab J Chem;30:320326.
  • 14
    Bansode S., Kamble R. (2011) Synthesis of novel 2-(3-aryl-sydnon-4-ylidene)-5-substituted-[1,3,4]-thiadiazolylamines and [1,3,4]-thiadiazol-2-yl-3-oxo-[1,2,4]-triazoles as antimicrobial agents. Med Chem Res;21:867873.
  • 15
    Padmavathi V., Reddy G.S., Padmaja A., Kondaiah P., Shazia A. (2011) Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles. Eur J Med Chem;44:21062112.
  • 16
    Jazayeri S., Moshafi M.H., Firoozpour L., Emami S., Rajabalian S., Haddad M., Pahlavanzadeh F., Esnaashari M., Shafiee A., Foroumadi A. (2008) Synthesis and antibacterial activity of nitroaryl thiadiazole–gatifloxacin hybrids. Eur J Med Chem;44:12051209.
  • 17
    Talath S., Gadad A.K. (2006) Synthesis, antibacterial and antitubercular activities of some 7-[4-(5-amino-[1,3,4]thiadiazole-2-sulfonyl)-piperazin-1-yl] fluoroquinolonic derivatives. Eur J Med Chem;41:918924.
  • 18
    Foroumadi A., Emami S., Hassanzadeh A., Rajaee M., Sokhanvar K., Moshafi M.H., Shafiee A. (2005) Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives. Bioorg Med Chem Lett;15:44884492.
  • 19
    Foroumadi A., Mansouri S., Emami S., Mirzaei J., Sorkhi M., Saeid-Adeli N., Shafiee A. (2006) Synthesis and antibacterial activity of nitroaryl thiadiazole- levofloxacin hybrids. Arch Pharm Chem Life Sci;339:621624.
  • 20
    Shelke S., Mhaske G., Gadakh S., Gill C. (2010) Green synthesis and biological evaluation of some novel azoles as antimicrobial agents. Bioorg Med Chem Lett;20:72007204.
  • 21
    Padmavathi V., Thriveni P., Reddy G.S., Deepti D. (2008) Synthesis and antimicrobial activity of novel sulfone-linked bis heterocycles. Eur J Med Chem;43:917924.
  • 22
    Chen C., Song B., Yang S., Xu G., Bhadury P.S., Jin L., Hu D., Li Q., Liu F., Xue W., Lu P., Chen Z. (2007) Synthesis and antifungal activities of 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-thiadiazole and 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-oxadiazole derivatives. Bioorg Med Chem;15:39813989.
  • 23
    Scozzafava A., Supuran C.T. (2002) Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions. Bioorg Med Chem Lett;12:26672672.
  • 24
    Demirbas A., Sahin D., Demirbas N., Karaoglu S.A. (2009) Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities. Eur J Med Chem;44:28962903.
  • 25
    Rostom S.A.F., El-Ashmawy I.M., Abd El Razik H.A., Badr M.H., Ashour H.M.A. (2009) Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents. Bioorg Med Chem;17:882895.
  • 26
    Ansari K.F., Lal C. (2009) Synthesis and evaluation of some new benzimidazole derivatives as potential antimicrobial agents. Eur J Med Chem;44:22942299.
  • 27
    Guzeldemirci N.U., Kucukbasmaci O. (2010) Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety. Eur J Med Chem;45:6368.
  • 28
    Liu X., Shi Y., Maa Y., Zhang C., Dong W., Pan L., Wang B., Li B., Li Z. (2009) Synthesis, antifungal activities and 3D-QSAR study of N-(5-substituted-1,3,4-thiadiazol-2-yl)cyclopropanecarboxamides. Eur J Med Chem;44:27822786.
  • 29
    Dogan H.N., Duran A., Rollas S., Sener G., Uysal M.K., Gulen D. (2002) Synthesis of new 2,5-disubstituted-1,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities. Bioorg Med Chem;10:28932898.
  • 30
    Farshori N.N., Banday M.R., Ahmad A., Khan A.U., Rauf A. (2010) Synthesis, characterization, and in vitro antimicrobial activities of 5-alkenyl/hydroxyalkenyl-2-phenylamine-1,3,4-oxadiazoles and thiadiazoles. Bioorg Med Chem Lett;20:19331938.
  • 31
    Onkol T., Dogruer D.S., Uzun L., Adak S., Ozkan S., Sahin M.F. (2008) Synthesis and antimicrobial activity of new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. J Enz Inhib Med Chem;23:277284.
  • 32
    Padmavathi V., Reddy S.N., Reddy G.D., Padmaja A. (2010) Synthesis and bioassay of aminosulfonyl-1,3,4-oxadiazoles and their interconversion to 1,3,4-thiadiazoles. Eur J Med Chem;45:42464251.
  • 33
    Klip N.T., Capan G., Gursoy A., Uzun M., Satana D. (2010) Synthesis, structure, and antifungal evaluation of some novel 1,2,4-triazolylmercaptoacetylthiosemicarbazide and 1,2,4-triazolylmercaptomethyl-1,3,4-thiadiazole analogs. J Enz Inhib Med Chem;25:126131.
  • 34
    Ranjina S., Devendra P.N., Ganpat L.T. (2006) Synthesis of various isoniazido thiazolidinones and their imidoxy derivatives of potential biological interest. Arkivoc;I:15.
  • 35
    Camoutsis C., Geronikaki A., Ciric A., Sokovic M., Zoumpoulakis P., Zervou M. (2010) Sulfonamide-1,2,4-thiadiazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies. Chem Pharm Bull;58:160167.
  • 36
    Kumar D., Kumar N.M., Chang K., Shah K. (2010) Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles. Eur J Med Chem;45:46644668.
  • 37
    Bhole R.P., Bhusari K.P. (2010) Synthesis and antitumor activity of (4-hydroxyphenyl)[5-substituted alkyl/aryl)-2-thioxo-1,3,4-thiadiazol-3-yl]methanone and [(3,4-disubstituted)-1,3-thiazol-2ylidene]-4-hydroxybenzohyd-razide. Med Chem Res;20:695704.
  • 38
    Kumar D., Vaddula R., Chang K., Shah K. (2011) One-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazoles. Bioorg Med Chem Lett;21:23202323.
  • 39
    Marganakop S.B., Kamble R.R., Taj T., Kariduraganvar M.Y. (2010) An efficient one-pot cyclization of quinoline thiosemicarbazones to quinolines derivatized with 1,3,4-thiadiazole as anticancer and anti-tubercular agents. Med Chem Res;21:185191.
  • 40
    Zheng K.B., He J., Zhang J. (2008) Synthesis and antitumor activity of N1-acetylamino-(5-alkyl/aryl-1,3,4-thiadiazole-2-yl)-5-fluorouracil derivatives. Chin Chem Lett;19:12811284.
  • 41
    Chou J., Lai S., Pan S., Jow G., Chern J., Guh J. (2003) Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells. Biochem Pharmacol;66:115124.
  • 42
    Matysiak J., Opolski A. (2006) Synthesis and antiproliferative activity of N-substituted 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles. Bioorg Med Chem;14:44834489.
  • 43
    Rzeski W., Matysiak J., Kandefer-Szerszen M. (2007) Anticancer, neuroprotective activities and computational studies of 2-amino-1,3,4-thiadiazole based compound. Bioorg Med Chem;15:32013207.
  • 44
    Matysiak J., Nasulewicz A., Pełczynska M., Switalska M., Jaroszewicz I., Opolski A. (2006) Synthesis and antiproliferative activity of some 5-substituted 2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles. Eur J Med Chem;41:475482.
  • 45
    Wei M., Feng L., Li X., Zhou X., Shao Z. (2009) Synthesis of new chiral 2,5-disubstituted 1,3,4-thiadiazoles possessing γ-butenolide moiety and preliminary evaluation of in vitro anticancer activity. Eur J Med Chem;44:33403344.
  • 46
    Sun S., Yang Y., Li W., Zhang Y., Wang X., Tang J., Zhu H. (2011) Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents. Bioorg Med Chem Lett;21:61166121.
  • 47
    Moshaf M.H., Sorkhi M., Emami S., Nakhjiri M., Yahya-Meymandi A., Negahbani A.S., Siavoshi F., Omrani M., Alipour E., Vosooghi M., Shafiee A., Foroumadi A. (2011) 5-Nitroimidazole-based 1,3,4-thiadiazoles: heterocyclic analogs of metronidazole as anti-Helicobacter pylori agents. Arch Pharm Chem Life Sci;11:178183.
  • 48
    Foroumadi A., Sorkhi M., Moshafi M.H., Safavi M., Rineh A., Siavoshi F., Shafiee A., Emami S. (2009) 2-Substituted-5-nitroheterocycles: in vitro anti-Helicobacter pylori activity and atructure-activity relationship study. Med Chem;5:529534.
  • 49
    Foroumadi A., Rineh A., Emami S., Siavoshi F., Massarrat S., Safari F., Rajabalian S., Falahati M., Lotfali E., Shafiee A. (2008) Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chain. Bioorg Med Chem Lett;18:33153320.
  • 50
    Mirzaei J., Siavoshi F., Emami S., Safari F., Khoshayand M.R., Shafiee A., Foroumadi A. (2008) Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4-thiadiazol-2-yl]thiomorpholines and related compounds. Eur J Med Chem;43:15751580.
  • 51
    Mohammadhosseini N., Letafat B., Siavoshi F., Emami S., Safari F., Shafiee A., Foroumadi A. (2008) Synthesis and in vitro anti-Helicobacter pylori activity of 2-[(chlorobenzyl)thio]-5-(5-nitro-2-furyl)-1,3,4-thiadiazoles. Med Chem Res;17:578586.
  • 52
    Locher W., Schmidt D. (2002) New horizons in the development of antiepileptic drugs. Epilepsy Res;50:316.
  • 53
    Rajak H., Deshmukh R., Aggarwal N., Kashaw S., Kharya M.D., Mishra P. (2009) Synthesis of novel 2,5-disubstituted 1,3,4-thiadiazoles for their potential anticonvulsant activity: pharmacophoric model studies. Arch Pharm Chem Life Sci;342:453461.
  • 54
    Siddiqui N., Ahsan W. (2011) Synthesis, anticonvulsant and toxicity screening of thiazolyl–thiadiazole derivatives. Med Chem Res;20:261268.
  • 55
    Dogan H.N., Duran A., Rollas S., Sener G., Uysal M.K., Gulen D. (2002) Synthesis of new 2,5-disubstituted-1,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities. Bioorg Med Chem;10:28932898.
  • 56
    Srivastava V.K., Kumar A. (2004) Synthesis of some newer derivatives of substituted quinazolinonyl-2-oxo/thiobarbituric acid as potent anticonvulsant agents. Bioorg Med Chem;12:12571264.
  • 57
    Masereel B., Rolin S., Abbate F., Scozzafava A., Supuran C.T. (2002) Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. J Med Chem;45:312320.
  • 58
    Kadi A.A., Al-Abdullah E.S., Shehata I.A., Habib E.E., Ibrahim T.M., El-Emam A.A. (2010) Synthesis antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives. Eur J Med Chem;45:50065010.
  • 59
    Sainy J., Mishra G.P., Sharma R., Chaturvedi S.C. (2009) 2-Amino-5-sulfanyl-1,3,4-thiadiazoles: a novel series of anti-inflammatory and analgesic agents. Pharm Chem J;43:1924.
  • 60
    Bhati S.K., Kumar A. (2008) Synthesis of new substituted azetidinoyl and thiazolidinoyl-1,3,4-thiadiazino (6,5-b) indoles as promising anti-inflammatory agents. Eur J Med Chem;43:23232330.
  • 61
    Kumar H., Javed S.A., Khan S.A., Amir M. (2008) 1,3,4 Oxadiazole/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: synthesis and preliminary evaluation of biological properties. Eur J Med Chem;43:26882698.
  • 62
    Amir M., Kumar H., Javed S.A. (2007) Non-carboxylic analogues of naproxen: design, synthesis, and pharmacological evaluation of some 1,3,4-oxadiazole/thiadiazole and 1,2,4-triazole derivatives. Arch Pharm Chem Life Sci;340:577585.
  • 63
    Schenone S., Brullo C., Bruno O., Bondavalli F., Ranise A., Filippelli W., Rinaldi B., Capuano A., Falcone G. (2006) New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities. Bioorg Med Chem;14:16981705.
  • 64
    Salgin-Goksen U., Gokhan-Kelekci N., Goktas O., Koysal Y., Kilic E., Isik S., Aktay G., Ozalp M. (2007) 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities. Bioorg Med Chem;15:57385751.
  • 65
    Rostom S.A.F., El-Ashmawy I.M., Abd El Razik H.A., Badr M.H., Ashour H.M.A. (2009) Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents. Bioorg Med Chem;17:882895.
  • 66
    Hafez H.N., Hegab M.I., Ahmed-Farag I.S., El-Gazzar A.B.A. (2008) A facile regioselective synthesis of novel spiro-thioxanthene and spiro-xanthene-90,2-[1,3,4]thiadiazole derivatives as potential analgesic and anti-inflammatory agents. Bioorg Med Chem Lett;18:45384543.
  • 67
    Foroumadi A., Soltani F., Jabini R., Moshafi M.H., Rasnani F.M. (2004) Antituberculosis agents X. synthesis and evaluation of In Vitro antituberculosis activity of 2-(5-nitro-2-furyl)- and 2-(1-methyl-5-nitro-lH-imidazol-2-yl)-1,3,4-thiadiazole derivatives. Arch Pharm Res;27:502506.
  • 68
    Foroumadi A., Soltani S., Moallemzadeh-Haghighi H., Shafiee A. (2005) Synthesis, in vitro-antimycobacterial activity and cytotoxicity of some alkyl α-(5-aryl-1,3,4-thiadiazole-2-ylthio)acetates. Arch Pharm Chem Life Sci;338:112116.
  • 69
    Foroumadi Z., Kiani F., Soltani F (2003) Antituberculosis agents, VIII: synthesis and in vitro antimycobacterium activity of alkyl α-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazol-2-ylthio]acetate. Il Farmaco;58:10731076.
  • 70
    Foroumadi A., Mirzaei M., Shafiee A. (2001) Antituberculosis agents II. Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole derivatives. Il Farmaco;56:621623.
  • 71
    Oruc E.E., Rollas S., Kandemirli F., Shvets N., Dimoglo A.S. (2004) 1,3,4-Thiadiazole derivatives. Synthesis, structure elucidation, and structure-antituberculosis activity relationship investigation. J Med Chem;47:67606767.
  • 72
    Chitra S., Paul N., Muthusubramanian S., Manisankar P., Yogeeswari P., Sriram D. (2011) Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies. Eur J Med Chem;46:48974903.
  • 73
    Marganakop S.B., Kamble R.R., Taj T., Kariduraganvar M.Y. (2010) An efficient one-pot cyclization of quinoline thiosemicarbazones to quinolines derivatized with 1,3,4-thiadiazole as anticancer and anti-tubercular agents. Med Chem Res;21:185191.
  • 74
    Mamolo M.G., Falagiani V., Zampieri D., Vio L., Banfi E. (2001) Synthesis and antimycobacterial activity of [5-(pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives. Il Farmaco;56:587592.
  • 75
    Mamolo M.G., Falagiani V., Zampieri D., Vio L., Banfi E., Scialino G. (2003) Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives. Il Farmaco;58:631637.
  • 76
    Karakus S., Rollas S. (2002) Synthesis and antituberculosis activity of new N-phenyl-N'-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl]thioureas. Il Farmaco;57:577581.
  • 77
    Hadizadeh F., Vosooghi R. (2008) Synthesis of α-[5-(5-Amino-1,3,4-thiadiazol-2-yl)-2- imidazolylthio]acetic acids. J Heterocyclic Chem;45:14771479.
  • 78
    Barreca M.L., Chimirri A., Luca L.D., Monforte A.M., Monforte P., Rao A., Zappala M., Balzarini J., Clercq E.D., Pannecouque C., Witvrouw M. (2001) Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents. Bioorg Med Chem Lett;11:17931796.
  • 79
    Hamad N.S., Al-Haidery N.H., Al-Masoudi I.A., Sabri M., Sabri L., Al-Masoudi N.A. (2010) Amino acid derivatives, part 4: synthesis and anti-HIV activity of new naphthalene derivatives. Arch Pharm Chem Life Sci;343:397403.
  • 80
    Chen Z., Xu W., Liu K., Yang S., Fan H., Bhadury P.S., Hu D., Zhang Y. (2010) Synthesis and antiviral activity of 5-(4-chlorophenyl)-1,3,4-thiadiazole sulfonamides. Molecules;15:90469056.
  • 81
    Navarro M., Cisneros Fajardo E.J., Fernandez Mestre M., Arrieche D., Marchan E. (2000) Synthesis, characterization, DNA binding study and biological activity against Leishmania mexicana. J Inorg Biochem;97:364369.
  • 82
    Alipour E., Emami S., Meymand Yahya A., Nakhjiri M., Johari F., Ardestani S.K., Poorrajab F., Hosseini M., Shafiee A., Foroumadi A. (2011) Synthesis and antileishmanial activity of 5-(5-nitroaryl)-2-substituted-thio-1,3,4-thiadiazoles. J Enz Inhib Med Chem;26:123128.
  • 83
    Foroumadi A., Pournourmohammadi S., Soltani F., Rezaee Asgharian M., Dabiri S., Kharazmi A., Shafiee A. (2005) Synthesis and in vitro leishmanicidal activity of 2-(5-nitro-2-furyl) and 2-(5-nitro-2-thienyl)-5-substituted-1,3,4-thiadiazoles. Bioorg Med Chem Lett;15:19831985.
  • 84
    Tahghighi A., Marznaki F.R., Kobarfard F., Dastmalchi S., Mojarrad J.S., Razmi S., Ardestani S.K., Emami S., Shafiee S., Foroumadi A. (2011) Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents. Eur J Med Chem;46:26022608.
  • 85
    Behrouzi-Fardmoghadam M., Poorrajab F., Ardestani S.K., Emami S., Shafiee A., Foroumadi A. (2008) Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4 aroylpiperazines. Bioorg Med Chem;16:45094515.
  • 86
    Poorrajab F., Ardestani S.K., Foroumadi A., Emami S., Kariminia A., Behrouzi-Fardmoghadam M., Shafiee A. (2009) Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species. Exp Parasitol;121:323330.
  • 87
    Poorrajab F., Ardestani S.K., Emami S., Behrouzi-Fardmoghadam M., Shafiee A., Foroumadi A. (2009) Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: synthesis and in vitro biological evaluation. Eur J Med Chem;44:17581762.
  • 88
    Higuchi M.L., Benvenuti L.A., Reis M.M., Metzger M. (2003) Pathophysiology of the heart in Chagas'disease: current status and new developments. Cardiovasc Res;60:96107.
  • 89
    Carvalho S.A., Silva E.F., Santa-Rita R.M., Castro S.L., Fraga C.A.M. (2004) Synthesis and antitrypanosomal profile of new functionalized 1,3,4-thiadiazole-2-arylhydrazone derivatives, designed as non-mutagenic megazol analogues. Bioorg Med Chem Lett;14:59675970.
  • 90
    Salomao K., Souza E.M., Carvalho S.A., Silva E.E., Fraga C.A.M., Barbosa H.S., Castro S.L. (2010) In vitro and in vivo activity of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol on Trypanosoma cruzi. Antimicrob Agents Chemother;54:20232031.
  • 91
    Carvalho S.A., Lopes F.A.S., Salomao K., Romeiro N.C., Wardell S.M., Castro S.L., Silva E.F., Fraga C.A.M. (2008) Studies toward the structural optimization of new brazilizonerelated trypanocidal 1,3,4-thiadiazole-2-arylhydrazone derivatives. Bioorg Med Chem;16:413421.
  • 92
    Chauviere G., Bouteille B., Enanga B., Albuquerque C., Croft S.L., Dumas M., Perie J. (2003) Synthesis and biological activity of nitro heterocycles analogous to megazol, a trypanocidal lead. J Med Chem;46:427440.
  • 93
    Supuran C.T. (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov;7:168181.
  • 94
    Krishnamurthy V.M., Kaufman G.K., Urbach A.R., Gitlin I., Gudiksen K.L., Weibel D.B., Whitesides G.M. (2008) Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding. Chem Rev;108:9461051.
  • 95
    Maresca A., Supuran C.T. (2011) (R)-/(S)-10-Camphorsulfonyl-substituted aromatic/heterocyclic sulfonamides selectively inhibit mitochondrial over cytosolic carbonic anhydrases. Bioorg Med Chem Lett;21:13341337.
  • 96
    Nishimori I., Minakuchi T., Vullo D., Scozzafava A., Supuran C.T. (2011) Inhibition studies of the b-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates. Bioorg Med Chem;19:50235030.
  • 97
    Cecchi A., Winum J., Innocenti A., Vullo D., Montero J., Scozzafava A., Supuran C.T. (2004) Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide. Bioorg Med Chem Lett;14:57755780.
  • 98
    Ozensoy O., Nishimori I., Vullo D., Puccetti L., Scozzafava A., Supuran C.T. (2005) Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides. Bioorg Med Chem;13:60896093.
  • 99
    Turkmen H., Durgun M., Yilmaztekin S., Emul M., Innocenti A., Vullo D., Scozzafava A., Supuran C.T. (2005) Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX. Bioorg Med Chem Lett;15:367372.
  • 100
    Scozzafava A., Supuran C.T. (2002) Carbonic anhydrase inhibitors. preparation of potent sulfonamides inhibitors incorporating bile acid tails. Bioorg Med Chem Lett;12:15511557.
  • 101
    Kasımogullari R., Bulbul M., Arslan B.S., Gokce B. (2010) Synthesis, characterization and antiglaucoma activity of some novel pyrazole derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide. Eur J Med Chem;45:47694773.
  • 102
    Ilies M.A., Vullo D., Pastorek J., Scozzafava A., Ilies M., Caproiu M.T., Pastorekova S., Supuran C.T. (2003) Carbonic anhydrase inhibitors. inhibition of tumor-associated isozyme ix by halogenosulfanilamide and halogenophenyl-aminobenzolamide derivatives. J Med Chem;46:21872196.
  • 103
    Nishimori I., Minakuchi T., Morimoto K., Sano S., Onishi S., Takeuchi H., Vullo D., Scozzafava A., Supuran C.T. (2006) Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the α-Carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J Med Chem;49:21172126.
  • 104
    Masereel B., Rolin S., Abbate F., Scozzafava A., Supuran C.T. (2002) Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. J Med Chem;45:312320.
  • 105
    Vergne F., Bernardelli P., Lorthiois E., Pham N., Proust E., Oliveira C., Mafroud A. et al. (2004) Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: design, synthesis and structure–activity relationship studies. Bioorg Med Chem Lett;14:46074613.
  • 106
    Vergne F., Bernardelli P., Lorthiois E., Pham N., Proust E., Oliveira C., Mafroud A. et al. (2004) Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 2: metabolism-directed optimization studies towards orally bioavailable derivatives. Bioorg Med Chem Lett;14:46154621.
  • 107
    De S.K., Chen V., Stebbins J.L., Chen L., Cellitti J.F., Machleidt T., Barile E., Riel-Mehan M., Dahl D., Yang L., Emdadi A., Murphy R., Pellecchia M. (2010) Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors. Bioorg Med Chem;18:590596.
  • 108
    De S.K., Chen V., Stebbins J.L., Chen L., Riel-Mehan M., Machleidt T., Dahl R., Yuan H., Emdadi A., Barile E., Chen V., Murphy R., Pellecchia M. (2009) Design, synthesis, and structure-activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-jun N-terminal kinase. J Med Chem;52:19431952.
  • 109
    Xiao D., Palani A., Sofolarides M., Huang Y., Aslanian R., Vaccaro H., Hong L., McKittrick B., West R.E. Jr, Williams S.M., Wub R., Hwa J., Sondey C., Lachowicz J. (2011) Discovery of a series of potent arylthiadiazole H3 antagonists. Bioorg Med Chem Lett;21:861864.